123 related articles for article (PubMed ID: 12555994)
1. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis.
Yao T; Takata M; Tustsumi S; Nishiyama K; Taguchi K; Nagai E; Tsuneyoshi M
Pathology; 2002 Dec; 34(6):556-60. PubMed ID: 12555994
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior.
Yao T; Tsutsumi S; Akaiwa Y; Takata M; Nishiyama K; Kabashima A; Tsuneyoshi M
Jpn J Cancer Res; 2001 Jul; 92(7):755-61. PubMed ID: 11473726
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M
Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728
[TBL] [Abstract][Full Text] [Related]
4. CD10 expression in colorectal carcinoma correlates with liver metastasis.
Fujimoto Y; Nakanishi Y; Sekine S; Yoshimura K; Akasu T; Moriya Y; Shimoda T
Dis Colon Rectum; 2005 Oct; 48(10):1883-9. PubMed ID: 16175325
[TBL] [Abstract][Full Text] [Related]
5. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
[TBL] [Abstract][Full Text] [Related]
6. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y
Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574
[TBL] [Abstract][Full Text] [Related]
7. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
[TBL] [Abstract][Full Text] [Related]
8. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.
Tajima Y; Yamazaki K; Makino R; Nishino N; Aoki S; Kato M; Morohara K; Kaetsu T; Kusano M
Clin Cancer Res; 2006 Nov; 12(21):6469-79. PubMed ID: 17085661
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD10 and reduced MUC2 expression correlate with the development and progression of colorectal neoplasms.
Iwase T; Kushima R; Mukaisho K; Mitsufuji S; Okanoue T; Hattori T
Pathol Res Pract; 2005; 201(2):83-91. PubMed ID: 15901128
[TBL] [Abstract][Full Text] [Related]
10. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
13. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
Mizoshita T; Tsukamoto T; Inada KI; Hirano N; Tajika M; Nakamura T; Ban H; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
[TBL] [Abstract][Full Text] [Related]
14. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract][Full Text] [Related]
15. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
[TBL] [Abstract][Full Text] [Related]
16. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
17. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
[TBL] [Abstract][Full Text] [Related]
18. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic alteration in malignant transformation of colonic villous tumours: with special reference to a comparison with tubular tumours.
Takata M; Yao T; Nishiyama KI; Nawata H; Tsuneyoshi M
Histopathology; 2003 Oct; 43(4):332-9. PubMed ID: 14511251
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
